{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:40:30Z","timestamp":1773866430582,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00415-018-8931-7","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T06:42:10Z","timestamp":1529044930000},"page":"1880-1882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML"],"prefix":"10.1007","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6624-8565","authenticated-orcid":false,"given":"Jeremias","family":"Motte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina","family":"Kneiphof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Stra\u00dfburger-Krogias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Klasing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ortwin","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiden","family":"Haghikia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"key":"8931_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.msard.2017.01.006","volume":"12","author":"JR Berger","year":"2017","unstructured":"Berger JR (2017) Classifying PML risk with disease modifying therapies. Mult Scler Relat Disord 12:59\u201363. \n                    https:\/\/doi.org\/10.1016\/j.msard.2017.01.006","journal-title":"Mult Scler Relat Disord"},{"key":"8931_CR2","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1056\/NEJMc1415408","volume":"372","author":"T Rosenkranz","year":"2015","unstructured":"Rosenkranz T, Novas M, Terborg C (2015) PML in a patient with lymphocytopenia treated with dimethyl fumarate. N Engl J Med 372:1476\u20131478. \n                    https:\/\/doi.org\/10.1056\/NEJMc1415408","journal-title":"N Engl J Med"},{"key":"8931_CR3","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1212\/NXI.0000000000000274","volume":"3","author":"M Baharnoori","year":"2016","unstructured":"Baharnoori M, Lyons J, Dastagir A et al (2016) Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm 3:e274. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000274","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8931_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1212\/WNL.0000000000002900","volume":"87","author":"K Lehmann-Horn","year":"2016","unstructured":"Lehmann-Horn K, Penkert H, Grein P et al (2016) PML during dimethyl fumarate treatment of multiple sclerosis: how does lymphopenia matter? Neurology 87:440\u2013441. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002900","journal-title":"Neurology"},{"key":"8931_CR5","unstructured":"European Medicines Agency (2017) Tecfidera-procedural steps taken and scientific information after the authorisation"},{"key":"8931_CR6","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1212\/NXI.0000000000000235","volume":"3","author":"EO Major","year":"2016","unstructured":"Major EO, Nath A (2016) A link between long-term natalizumab dosing in MS and PML: putting the puzzle together. Neurol Neuroimmunol Neuroinflamm 3:e235. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000235","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8931_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev.med.080708.082655","volume":"61","author":"EO Major","year":"2010","unstructured":"Major EO (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61:35\u201347. \n                    https:\/\/doi.org\/10.1146\/annurev.med.080708.082655","journal-title":"Annu Rev Med"},{"key":"8931_CR8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1177\/1352458515608961","volume":"22","author":"EE Longbrake","year":"2016","unstructured":"Longbrake EE, Ramsbottom MJ, Cantoni C et al (2016) Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients. Mult Scler J 22:1061\u20131070. \n                    https:\/\/doi.org\/10.1177\/1352458515608961","journal-title":"Mult Scler J"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8931-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8931-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8931-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T19:09:13Z","timestamp":1560539353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8931-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["8931"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8931-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]},"assertion":[{"value":"3 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving humans participants were in accordance with the ethical standard of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendment or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"The patient gave consent prior to participation to the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}